Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Yasaman Mahdavian"'
Autor:
Arianna Nicolussi, Francesca Belardinilli, Valentina Silvestri, Yasaman Mahdavian, Virginia Valentini, Sonia D’Inzeo, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Stefano Di Giulio, Francesca Fabretti, Beatrice Fratini, Angela Gradilone, Laura Ottini, Giuseppe Giannini, Anna Coppa, Carlo Capalbo
Publikováno v:
PeerJ, Vol 7, p e7972 (2019)
Background Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires screening for single nucleotide variants, small insertions/deletions and large genomic rearrangements (LGRs). These studies have long been
Externí odkaz:
https://doaj.org/article/85e327b29acf4025bee0ed5b00f74e12
Autor:
Arianna Nicolussi, Francesca Belardinilli, Yasaman Mahdavian, Valeria Colicchia, Sonia D’Inzeo, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Virginia Valentini, Laura Ottini, Giuseppe Giannini, Carlo Capalbo, Anna Coppa
Publikováno v:
PeerJ, Vol 7, p e6661 (2019)
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://doaj.org/article/af709bd668db45ada5e1a66a6ebf63d9
Autor:
Francesca Belardinilli, Giulia d'Amati, Yasaman Mahdavian, Marco Anile, Angelina Pernazza, Maria Gemma Pignataro, Giuseppe Giannini, Bruna Cerbelli, Carlo Della Rocca, Anna Coppa, Federico Venuta, Massimiliano Bassi, Angela Gradilone
Publikováno v:
Pathology, research and practice. 220
Purpose The distinction between multiple primary lung cancers (MPLCs) and intrapulmonary metastases has a significant impact on tumor staging and therapeutic choices. Several criteria have been proposed to solve this diagnostic issue, but a definitiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9ef050a4c0966dfcb8442a9604a414f
https://pubmed.ncbi.nlm.nih.gov/33647865
https://pubmed.ncbi.nlm.nih.gov/33647865
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Stefano Di Giulio, Francesca Belardinilli, Virginia Valentini, Carlo Capalbo, Sonia D'Inzeo, Sergio Ferraro, Arianna Nicolussi, Massimo Zani, Giuseppe Giannini, Francesca Fabretti, Angela Gradilone, Yasaman Mahdavian, Beatrice Fratini, Marialaura Petroni, Anna Coppa, Valentina Silvestri, Laura Ottini
Publikováno v:
PeerJ
PeerJ, Vol 7, p e7972 (2019)
PeerJ, Vol 7, p e7972 (2019)
Background Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires screening for single nucleotide variants, small insertions/deletions and large genomic rearrangements (LGRs). These studies have long been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1550b5ae03cdc0f09ec7289649eb137a
http://europepmc.org/articles/PMC6859874
http://europepmc.org/articles/PMC6859874
Autor:
Yasaman Mahdavian, Francesca Belardinilli, Massimo Zani, Giuseppe Giannini, Anna Coppa, Sergio Ferraro, Virginia Valentini, Carlo Capalbo, Valeria Colicchia, Sonia D'Inzeo, Marialaura Petroni, Laura Ottini, Arianna Nicolussi
Publikováno v:
PeerJ, Vol 7, p e6661 (2019)
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a027fc8a4f14abb638ee412d31015024
http://hdl.handle.net/11573/1266940
http://hdl.handle.net/11573/1266940
Autor:
Francesca Belardinilli, Cristina Raimondi, Yasaman Mahdavian, Paola Gazzaniga, Flavia Loreni, Giuseppe Giannini, Angela Gradilone, Enrico Cortesi, Alain Gelibter, Chiara Nicolazzo
Publikováno v:
Cancers, Vol 11, Iss 1, p 42 (2019)
Cancers
Cancers
Genomic studies performed through liquid biopsies widely elucidated the evolutionary trajectory of RAS mutant clones under the selective pressure of EGFR inhibitors in patients with wild type RAS primary colorectal tumors. Similarly, the disappearanc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba96a8df83b0661fc39bf400c8d29e0
http://www.mdpi.com/2072-6694/11/1/42
http://www.mdpi.com/2072-6694/11/1/42
Autor:
Arianna, Nicolussi, Francesca, Belardinilli, Yasaman, Mahdavian, Valeria, Colicchia, Sonia, D'Inzeo, Marialaura, Petroni, Massimo, Zani, Sergio, Ferraro, Virginia, Valentini, Laura, Ottini, Giuseppe, Giannini, Carlo, Capalbo, Anna, Coppa
Publikováno v:
PeerJ
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6448a180448bfdd6234c6d6adb5e99c
https://pubmed.ncbi.nlm.nih.gov/31065452
https://pubmed.ncbi.nlm.nih.gov/31065452